Home

For relapsed multiple myeloma,

DISCOVER WHAT’S POSSIBLE

What is DARZALEX®?

DARZALEX® is a prescription medicine used to treat multiple myeloma:

  • In combination with the medicines lenalidomide and dexamethasone or bortezomib and dexamethasone, in people who have received at least one prior medicine to treat multiple myeloma
  • Alone in people who have received at least three prior medicines to treat multiple myeloma, including a proteasome inhibitor and an immunomodulatory agent, or did not respond to a proteasome inhibitor and an immunomodulatory agent

It is not known if DARZALEX® is safe and effective in children.

DARZALEX®—a Monoclonal Antibody

I’m interested in learning more about what DARZALEX® is and how it works.

DARZALEX® was studied as a combination therapy and as a monotherapy.

About DARZALEX®

DARZALEX® Is a CD38-Targeted Monoclonal Antibody

DARZALEX® is not chemotherapy. DARZALEX® is a monoclonal antibody that works in several ways. One way this monoclonal antibody works is by attaching itself to multiple myeloma cells in your body and directly killing them, and/or allowing your immune system to destroy them.

DARZALEX® targets and attaches to a protein called CD38, which is present on the surface of certain types of cells (eg, red blood cells) and is also present in high numbers on multiple myeloma cells. Since DARZALEX® targets the CD38 protein, it may also affect other cells with this protein on their surface.

DARZALEX® (daratumumab) Mechanisms of Action

DARZALEX® Treatment

My Treatment Schedule

Depending on where you are in your treatment journey, your doctor may discuss treatment with DARZALEX® as a monotherapy or a combination therapy.

Select the date on which you expect to receive your first DARZALEX® treatment. Once a date is selected, recommended subsequent treatment dates will automatically populate within the calendar.*

Tap a date to begin.
My Treatment Schedule

Depending on where you are in your treatment journey, your doctor may discuss treatment with DARZALEX® as a monotherapy or a combination therapy.

Select the date on which you expect to receive your first DARZALEX® treatment. Once a date is selected, recommended subsequent treatment dates will automatically populate within the calendar.*

Tap a date below to begin.

Infusion Dates
Weeks 1-8
Weekly Infusions
Weeks 1-8 (weekly infusions)
Weeks 9-24
Infusions Every 2 Weeks
Weeks 9-24 (infusions every 2 weeks)
Weeks 25+
Infusions Every 4 Weeks
Weeks 25+ (infusions every 4 weeks)

*Please note that dates provided are recommendations for infusion visits only. Your doctor is likely to schedule additional follow-up/care visits and may alter the dates for your infusions depending on your availability and office availability.

Infusion centers may not offer weekend and/or holiday appointments.

Please contact the center to confirm hours of operation.

You have chosen a new start date.

Would you like to clear your old dosing schedule and create a new one?

Please select the date you plan to receive your first DARZALEX® dose.
Please choose a dosing regimen.
DARZALEX® Monotherapy
DARZALEX® + lenalidomide + dexamethasone
DARZALEX® + bortezomib + dexamethasone
Choose PDF type

Please select the view mode for your dosing calendar.

Want a PDF of this treatment schedule?

How Is DARZALEX® Given?
Preparing for Treatment

Learn what you can expect before treatment with DARZALEX®.

Explore More
Patient and Caregiver Stories

Learn from patients on DARZALEX® and their caregivers about their experiences.

How Is DARZALEX® Given?
Infusion Tips

Learn about some useful tips to help you prepare for your infusion and feel comfortable during your appointments.

Janssen CarePath

Janssen CarePath provides ongoing support, education, and resources during your treatment with DARZALEX®.

Support at every step

Would you like to receive e-mails and other communications from Janssen CarePath that are designed to support you during your treatment journey with DARZALEX®?